Nutrien Stock Forecast, Price & News

11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Nutrien in the last year. There are currently 1 sell rating, 3 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Nutrien stock.
View analyst ratings for Nutrien or view top-rated stocks.

Wall Street analysts have given Nutrien a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Nutrien wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Nutrien saw a increase in short interest in the month of May. As of May 14th, there was short interest totaling 4,380,000 shares, an increase of 23.0% from the April 29th total of 3,560,000 shares. Based on an average daily volume of 1,930,000 shares, the days-to-cover ratio is presently 2.3 days. Currently, 0.8% of the shares of the company are short sold.
View Nutrien's Short Interest.

Nutrien is scheduled to release its next quarterly earnings announcement on Monday, August 9th 2021.
View our earnings forecast for Nutrien.

Nutrien Ltd. (NYSE:NTR) announced its quarterly earnings results on Sunday, May, 2nd. The company reported $0.29 EPS for the quarter, beating the Zacks' consensus estimate of $0.09 by $0.20. The business earned $4.66 billion during the quarter, compared to analysts' expectations of $4.37 billion. Nutrien had a net margin of 2.91% and a trailing twelve-month return on equity of 5.62%. The firm's revenue for the quarter was up 11.0% on a year-over-year basis. During the same quarter last year, the business earned ($0.12) EPS.
View Nutrien's earnings history.

Nutrien's stock was trading at $32.00 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, NTR shares have increased by 91.6% and is now trading at $61.30.
View which stocks have been most impacted by COVID-19.

Nutrien announced a quarterly dividend on Wednesday, May 19th. Shareholders of record on Wednesday, June 30th will be paid a dividend of $0.46 per share on Friday, July 16th. This represents a $1.84 annualized dividend and a dividend yield of 3.00%. The ex-dividend date of this dividend is Tuesday, June 29th.
View Nutrien's dividend history.

Nutrien pays an annual dividend of $1.35 per share and currently has a dividend yield of 2.20%. Nutrien does not yet have a strong track record of dividend growth. The dividend payout ratio of Nutrien is 75.00%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Nutrien will have a dividend payout ratio of 38.79% next year. This indicates that Nutrien will be able to sustain or increase its dividend.
View Nutrien's dividend history.

Nutrien updated its FY 2021 earnings guidance on Monday, May, 17th. The company provided earnings per share (EPS) guidance of 2.550-3.250 for the period. The company issued revenue guidance of -.

11 equities research analysts have issued 1 year price objectives for Nutrien's shares. Their forecasts range from $44.00 to $82.00. On average, they expect Nutrien's share price to reach $62.89 in the next twelve months. This suggests a possible upside of 2.6% from the stock's current price.
View analysts' price targets for Nutrien or view top-rated stocks among Wall Street analysts.

Some companies that are related to Nutrien include The Mosaic (MOS), CF Industries (CF), The Scotts Miracle-Gro (SMG), ICL Group (ICL), CVR Partners (UAN), Bioceres Crop Solutions (BIOX), American Vanguard (AVD), Marrone Bio Innovations (MBII), Calyxt (CLXT), AgroFresh Solutions (AGFS), Wynnstay Group (WYN), Evogene (EVGN), China Green Agriculture (CGA), Bion Environmental Technologies (BNET) and Eden Research (EDEN).
View all of NTR's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Nutrien investors own include AT&T (T), Pfizer (PFE), Johnson & Johnson (JNJ), General Electric (GE), Intel (INTC), Bank of America (BAC), CVS Health (CVS), AbbVie (ABBV), JPMorgan Chase & Co. (JPM) and Micron Technology (MU).

Nutrien trades on the New York Stock Exchange (NYSE) under the ticker symbol "NTR."

Nutrien's stock is owned by a number of institutional and retail investors. Top institutional investors include First Eagle Investment Management LLC (3.50%), TD Asset Management Inc. (1.81%), Bank of Montreal Can (1.79%), Arrowstreet Capital Limited Partnership (1.49%), Bank of Nova Scotia (1.40%) and Caisse DE Depot ET Placement DU Quebec (1.40%).

NTR stock was sold by a variety of institutional investors in the last quarter, including Great West Life Assurance Co. Can, Ameriprise Financial Inc., Caisse DE Depot ET Placement DU Quebec, First Eagle Investment Management LLC, Arrowstreet Capital Limited Partnership, BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp, Letko Brosseau & Associates Inc., and The Manufacturers Life Insurance Company.

NTR stock was bought by a variety of institutional investors in the last quarter, including Canada Pension Plan Investment Board, Mufg Securities Canada LTD., FIL Ltd, Nuveen Asset Management LLC, BlackRock Inc., Bank of Nova Scotia, Clal Insurance Enterprises Holdings Ltd, and TD Asset Management Inc..

Shares of NTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of NTR stock can currently be purchased for approximately $61.30.

Nutrien has a market capitalization of $34.95 billion and generates $20.91 billion in revenue each year. The company earns $459 million in net income (profit) each year or $1.80 on an earnings per share basis.

Nutrien employs 23,100 workers across the globe.

The official website for Nutrien is www.nutrien.com.

Nutrien is headquartered at SUITE 500 122 - 1ST AVENUE SOUTH, SASKATOON A9, S7K 7G3.

Nutrien's mailing address is SUITE 500 122 - 1ST AVENUE SOUTH, SASKATOON A9, S7K 7G3. The company can be reached via phone at 306-933-8500 or via email at [email protected]